Stay updated on MiST: Multi-drug Phase II Clinical Trial
Sign up to get notified when there's something new on the MiST: Multi-drug Phase II Clinical Trial page.

Latest updates to the MiST: Multi-drug Phase II Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedMiST study page now shows the trial is completed and no longer recruiting, with results posted (including 12- and 24-week disease control rate and objective response rate). It also adds several study documents and protocol PDFs to the page.SummaryDifference4%

- Check15 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a small update to the study record on ClinicalTrials.gov. This change does not alter core study content or user-facing information.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page revision tag changed from v3.6.3 to v3.6.4, indicating a minor maintenance update to the page template or content.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, indicating a maintenance or small improvement to the site. This change does not affect the study information or user-facing data.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2, indicating a newer release. This update does not imply changes to substantive study information.SummaryDifference0.1%

- Check73 days agoChange DetectedThe Study Details page now includes new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and new labels such as Last verified and Last known status was, alongside an updated Intervention/Treatment label. The older text labels Interventions / Treatment and Revision: v3.5.5 were removed, and the revision label was updated to v3.6.0.SummaryDifference1%

Stay in the know with updates to MiST: Multi-drug Phase II Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MiST: Multi-drug Phase II Clinical Trial page.